Oncology Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Oncology Clinical Trials in Brazil

Oncology Clinical Trials in Brazil – Full Service CRO

Oncology clinical trials have emerged as a driving force in advancing cancer treatment and care worldwide. In Brazil, a country at the forefront of medical research and innovation, these trials play a pivotal role in improving patient outcomes, expanding treatment options, and contributing to the global body of knowledge in oncology.

In this blog post, we will explore the significance of oncology clinical trials in Brazil, highlighting their impact on cancer care and the efforts made to advance research in the country.

Access to Cutting-Edge Treatments:

Oncology clinical trials in Brazil provide patients with access to cutting-edge treatments that may not be widely available through standard care. These trials evaluate novel therapies, targeted drugs, immunotherapies, and combination treatments, aiming to improve treatment efficacy and patient outcomes. By participating in clinical trials, Brazilian patients can benefit from innovative treatments that have the potential to transform cancer care.

Personalized Medicine Advancements:

Oncology clinical trials in Brazil are at the forefront of advancing personalized medicine approaches. By studying patient genetics, biomarkers, and tumor characteristics, researchers can identify specific subgroups of patients who are more likely to respond favorably to certain treatments.

This enables healthcare professionals to tailor treatments to individual patients, optimizing outcomes and reducing unnecessary side effects. Clinical trials in Brazil contribute to the development of biomarkers and companion diagnostics that guide targeted therapies.

Collaborations and Research Networks:

Brazil actively collaborates with international research networks, academic institutions, and pharmaceutical companies to conduct oncology clinical trials. This collaboration ensures that trials adhere to rigorous international standards, protocols, and ethical guidelines, ensuring the scientific rigor and integrity of the research.

 By participating in global research networks, Brazil contributes valuable data to international research efforts, enriching the understanding of cancer and improving patient care on a global scale.

Oncology Clinical Trials in Brazil

Oncology Clinical Trials in Brazil

Oncology Clinical Trials in Brazil

Expanding Treatment Options:

Oncology clinical trials in Brazil expand the range of treatment options available to cancer patients. These trials explore new drug combinations, alternative dosing schedules, and emerging therapeutic modalities.

By evaluating the efficacy and safety of these interventions, clinical trials provide physicians with crucial information to make evidence-based decisions regarding the most effective treatment strategies.

This benefits not only the patients enrolled in the trials but also future patients who can benefit from the knowledge gained.

Patient-Centric Care and Support:

Oncology clinical trials in Brazil prioritize patient-centered care and support throughout the trial process. Patients enrolled in clinical trials receive close monitoring, comprehensive assessments, and access to multidisciplinary care teams. This ensures that patients receive the highest standard of care and support throughout their participation in the trial.

Additionally, clinical trials often provide additional support services, such as psychological counseling, educational resources, and access to support groups, to address the unique needs of patients during and after the trial.

Advancing Local Expertise and Research:

Oncology clinical trials in Brazil contribute to the advancement of local expertise and research capabilities. These trials generate valuable data that inform future treatment guidelines, contribute to scientific knowledge, and foster the development of local research infrastructure.

By conducting clinical trials in Brazil, researchers and healthcare professionals gain expertise, strengthen collaborations with international partners, and attract global talent, solidifying Brazil’s position as a leading hub for cutting-edge cancer research.

Economic and Social Impact:

Oncology clinical trials in Brazil have a significant economic and social impact. These trials attract investment, create job opportunities, and stimulate the local economy. Additionally, the knowledge gained from clinical trials translates into improved healthcare outcomes, benefiting not only the patients involved but also the broader population.

Oncology Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Oncology Clinical Trials in Brazil

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Oncology Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Oncology Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Oncology Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Oncology Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Oncology Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Oncology Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Oncology Clinical Trials in Brazil

The Cohortias Team

Oncology Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Oncology Clinical Trials in Brazil

Network & Partnerships